Literature DB >> 21391131

Attentional deficits in fibromyalgia and its relationships with pain, emotional distress and sleep dysfunction complaints.

E Miró1, J Lupiáñez, E Hita, M P Martínez, A I Sánchez, G Buela-Casal.   

Abstract

Cognitive complaints are common among subjects with fibromyalgia (FM). Yet, few studies have been able to document these deficits with cognitive tasks. A main limitation of existing studies is that attention has been broadly defined and the tasks used to measure attention are not designed to cover all the main components of the attentional system. Research on attention has identified three primary functions of attention, known as alerting, orienting and executive functioning. This study used the attentional network test-interactions task to explore whether and which of the three attentional networks are altered in FM. Results showed that FM patients have impaired executive control (greater interference), reduced vigilance (slower overall reaction time) and greater alertness (higher reduction in errors after a warning cue). Vigilance and alertness showed several relations with depression, anxiety and sleep quality. Sleep dysfunction was a significant predictor for alertness, whereas there were no significant predictors for vigilance. These findings highlight that the treatment of sleep difficulties in FM patients may help with some of their cognitive complaints.
© 2011 Taylor & Francis

Entities:  

Mesh:

Year:  2011        PMID: 21391131     DOI: 10.1080/08870446.2010.493611

Source DB:  PubMed          Journal:  Psychol Health        ISSN: 0887-0446


  25 in total

Review 1.  Fibrofog and fibromyalgia: a narrative review and implications for clinical practice.

Authors:  Howard M Kravitz; Robert S Katz
Journal:  Rheumatol Int       Date:  2015-01-13       Impact factor: 2.631

2.  Attentional networks functioning and vigilance in expert musicians and non-musicians.

Authors:  Rafael Román-Caballero; Elisa Martín-Arévalo; Juan Lupiáñez
Journal:  Psychol Res       Date:  2020-03-30

3.  Fibrofog in Daily Life: An Examination of Ambulatory Subjective and Objective Cognitive Function in Fibromyalgia.

Authors:  Anna L Kratz; Daniel Whibley; Samsuk Kim; Martin Sliwinski; Daniel Clauw; David A Williams
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-11-09       Impact factor: 4.794

Review 4.  Neuroimaging of Central Sensitivity Syndromes: Key Insights from the Scientific Literature.

Authors:  Brian Walitt; Marta Ceko; John L Gracely; Richard H Gracely
Journal:  Curr Rheumatol Rev       Date:  2016

5.  The relationship between the fear-avoidance model of pain and personality traits in fibromyalgia patients.

Authors:  María Pilar Martínez; Ana Isabel Sánchez; Elena Miró; Ana Medina; María José Lami
Journal:  J Clin Psychol Med Settings       Date:  2011-12

6.  Cognitive-behavioral therapy for insomnia and sleep hygiene in fibromyalgia: a randomized controlled trial.

Authors:  M Pilar Martínez; Elena Miró; Ana I Sánchez; Carolina Díaz-Piedra; Rafael Cáliz; Johan W S Vlaeyen; Gualberto Buela-Casal
Journal:  J Behav Med       Date:  2013-06-07

7.  Increased attentional network functioning related to symptom severity measures in females with irritable bowel syndrome.

Authors:  C S Hubbard; J Hong; Z Jiang; B Ebrat; B Suyenobu; S Smith; N Heendeniya; B D Naliboff; K Tillisch; E A Mayer; J S Labus
Journal:  Neurogastroenterol Motil       Date:  2015-06-19       Impact factor: 3.598

Review 8.  Fibromyalgia: A Critical and Comprehensive Review.

Authors:  Andrea T Borchers; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

9.  Neurobiology underlying fibromyalgia symptoms.

Authors:  Marta Ceko; M Catherine Bushnell; Richard H Gracely
Journal:  Pain Res Treat       Date:  2011-10-27

10.  Assessing Cognitive and Psychomotor Performance in Patients with Fibromyalgia Syndrome.

Authors:  Sergey Shmygalev; Oguzhan Dagtekin; Hans Jürgen Gerbershagen; Hanke Marcus; Martin Jübner; Rainer Sabatowski; Frank Petzke
Journal:  Pain Ther       Date:  2014-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.